Toludesvenlafaxine hydrochloride extended-release tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Toludesvenlafaxine hydrochloride extended-release tablets, covering 2023-10-19 to 2023-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) [Phase 4]